Unlike directly inhibiting Hsp90, specifically targeting these Hsp90/co-chaperones PPIs can modulate Hsp90 function by “fine-tuning” and provide an alternative therapeutic strategy for neurodegenerative diseases. The gene discussed is AQP1; the disease is neurodegenerative disease.